Dec 5 (Reuters) - Australian shares rose on Monday, as miners jumped on hopes that COVID-19 restrictions in China would be eased, with investors eyeing the central bank's policy meeting this week where they expect another interest rate hike of 25 basis points.
The S&P/ASX 200 index (xjo) added 0.3% to 7,325.9 points by 2333 GMT. The benchmark fell 0.7% on Friday.
The Reserve Bank of Australia is expected to deliver a quarter-point rate hike — its third in a row after a succession of half-point moves — at its upcoming policy meeting on Tuesday as the country showed signs of cooling inflation, according to a Reuters poll.
Financials .AXIJ advanced 0.1%, with the "Big Four" banks gaining between 0.1% and 0.3%.
Local miners .AXMM climbed 1.7% and were among the top gainers on the benchmark after iron ore prices were buoyed by expectations that top steelmaker China would ease its stringent COVID-19 policies.
Iron ore behemoths BHP (BHP) and Rio Tinto (RIO) gained 1.7% and 0.9%, respectively.
Energy stocks .AXEJ gained 0.2%. Sector major Woodside Energy (WDS) and Beach Energy (BPT) rose 0.06% and 0.4%, respectively.
Separately, Santos (STO) added 0.6% even as Australia's Federal Court on Friday rejected its appeal to resume drilling on its $3.6 billion Barossa gas project.
Tech stocks .AXIJ lost 0.4%. ASX-listed shares of Block Inc (SQ2) slid 0.9%, while software solution provider Wisetech Global (WTC) slid 1.3% and was among the top losers on the sub-index.
Weakness in bullion prices led gold stocks .AXGD to drop 0.5%. The country's largest gold miner Newcrest Mining (NCM) slipped 0.2%.
In New Zealand, the benchmark S&P/NZX 50 index (nz50) fell 0.4% to 11,590.83 points.
- Forums
- ASX - By Stock
- XIJ
- News: XIJ Australian shares gain on mining boost, cenbank decision in focus
News: XIJ Australian shares gain on mining boost, cenbank decision in focus
Featured News
Add XIJ (ASX) to my watchlist
|
|||||
Last
2,379.6 |
Change
3.400(0.14%) |
Mkt cap ! n/a |
Open | High | Low |
2,376.2 | 2,382.1 | 2,370.7 |
Featured News
XIJ (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online